El Salvador vs Singapore: Hypertension effective treatment coverage (controlled hypertension)
El Salvador
39.4%
in 2019
Singapore
37.6%
in 2019
El Salvador rank
9th
Singapore rank
11th
Hypertension effective treatment coverage (controlled hypertension) over time
- El Salvador
- Singapore
How they compare
El Salvador currently reports 39.4% against 37.6% in Singapore, a difference of 1.8%.
Across all 30 years both countries report, El Salvador has been ahead every year.
El Salvador ranks 9th and Singapore ranks 11th of 193 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14.0% | 6.6% | 7.4% | El Salvador |
| 2000s | 23.3% | 16.4% | 6.9% | El Salvador |
| 2010s | 35.5% | 31.5% | 3.9% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), El Salvador or Singapore?
- El Salvador, at 39.4% against 37.6% in Singapore as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between El Salvador and Singapore?
- 1.8%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Singapore?
- 30 years are reported by both, from 1990 to 2019.
- How do El Salvador and Singapore rank globally for hypertension effective treatment coverage (controlled hypertension)?
- El Salvador ranks 9th and Singapore ranks 11th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.